Gary Charles Robb, Chief Financial Officer at CORCEPT THERAPEUTICS INC (CORT), sold 30,000 shares at $13.73 ($412K) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $412k CORT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CORT | SELL | 2025-06-18 | $451K | — | Filing → |
| CORT | SELL | 2025-05-22 | $346K | — | Filing → |
| CORT | SELL | 2025-01-06 | $556K | — | Filing → |